Evaluating the World Health Organization Model List of Essential Medicines for skin disease
Br J Dermatol
.
2021 Aug;185(2):451-453.
doi: 10.1111/bjd.20081.
Epub 2021 Jun 1.
Authors
C W Rundle
1
,
A P Fortugno
2
,
J Maghfour
3
,
C L Presley
4
,
K Pulsipher
4
,
S S Husayn
4
,
L Naldi
5
6
,
O Chosidow
7
,
R Hay
8
,
R P Dellavalle
1
9
10
Affiliations
1
Department of Dermatology, University of Colorado School of Medicine, Aurora, CO, USA.
2
Medical School, University of Tennessee Health Science Center, Memphis, TN, USA.
3
Department of Medicine, Tulane University School of Medicine, New Orleans, LA, USA.
4
College of Osteopathic Medicine, Rocky Vista University, Parker, CO, USA.
5
Department of Dermatology, Azienda Sanitaria Berica, Ospedale San Bortolo, Vicenza, Italy.
6
Study Center, Italian Group for Epidemiological Research in Dermatology (GISED), Bergamo, Italy.
7
Department of Dermatology, AP-HP, Hôpital Henri Mondor UPEC, Créteil, France.
8
St Johns Institute of Dermatology, Kings College London, London, SE1, UK.
9
Dermatology Service, U.S. Department of Veterans Affairs, Eastern Colorado Health Care System, Aurora, Colorado, USA.
10
Department of Epidemiology, Colorado School of Public Health, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
PMID:
33764503
DOI:
10.1111/bjd.20081
No abstract available
Publication types
Letter
MeSH terms
Drugs, Essential*
Humans
Skin Diseases* / drug therapy
World Health Organization
Substances
Drugs, Essential